Latest filing published 30 Oct 2026 for BELITE BIO, INC, €5,316.
Filing timeline
BuySaleInsider track record
No signal scores available.
Wan-Shan Chen: trading record in brief
Wan-Shan Chen discloses dealings in Belite Bio, Inc to SEC (Form 4). In total, 2 filings cover trades dated from 9 April 2026 to 24 September 2026.
On the market, this insider has only sold: 1 sale, €170k in total. Besides market trades, the filings include 1 share grant.
Most recently, on 30 October 2026, the filings show a share grant worth €5,316 in Belite Bio, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Wan-Shan Chen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,796 shares@ US$0.4386Ordinary ShareSEC:0001193125-26-442228:0
- 1,100 shares@ US$180.4301100.0% of flowAmerican depositary shareSEC:0001193125-26-152884:0
2 of 2 declarations
